Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar;23(1):333-339.
doi: 10.1007/s11325-018-1711-x. Epub 2018 Aug 29.

Sleep phenotype in the Townes mouse model of sickle cell disease

Brett J O'Donnell  1 , Lanping Guo  1 , Samit Ghosh  1 , Faraaz A Shah  1 , Patrick J Strollo Jr  1 , Bryan J McVerry  1 , Mark T Gladwin  1 , Solomon F Ofori-Acquah  2 , Gregory J Kato  2 , Christopher P O'Donnell  3
Affiliations

Sleep phenotype in the Townes mouse model of sickle cell disease

Brett J O'Donnell et al. Sleep Breath. 2019 Mar.

Abstract

Purpose: Patients with sickle cell disease (SCD) regularly experience abnormal sleep, characterized by frequent arousals and reduced total sleep time. However, obstructive sleep apnea syndrome (OSAS) is a common comorbidity of SCD, making it unclear whether the disease per se is impacting sleep, or sleep disruption is secondary to the presence of OSAS. Thus, we assessed sleep, independent of OSAS, using a mouse model of SCD.

Methods: Sleep was compared between 10-to-12-week-old Townes knockout-transgenic mice with the sickle cell phenotype SS (n = 6) and Townes mice with sickle cell trait AS (n = 6; control). The mice underwent chronic polysomnographic electrode implantation (4EEG/2EMG) to assess sleep architecture.

Results: The SS mice had significantly lower hemoglobin concentration compared to control AS mice (7.3 ± 1.3 vs. 12.9 ± 1.7 g/dL; p < 0.01), consistent with the expected SCD phenotype. SS mice exhibited significantly decreased total NREM sleep time (45.0 ± 0.7 vs. 53.0 ± 1.3% 24 h sleep time; p < 0.01), but no change in total REM sleep time compared to the AS mice. The SS mice took longer to resume sleep after a wake period compared to the AS mice (3.2 ± 0.3 min vs. 1.9 ± 0.2 min; p < 0.05). Unexpectedly, SS mice experienced fewer arousals compared to AS mice (19.0 ± 0.9 vs. 23.3 ± 2.1 arousals/h of sleep; p = 0.031).

Conclusions: The presence of decreased total NREM sleep associated with reduced arousals, in the absence of OSAS, suggests a distinctive underlying sleep phenotype in a mouse model of SCD.

Keywords: Arousals; Hemoglobin; Sickle cell disease; Sleep.

PubMed Disclaimer

Conflict of interest statement

All procedures performed in studies involving animals were in accordance with the ethical standards of the University of Pittsburgh at which the studies were conducted.

Figures

Fig. 1
Fig. 1
Mean ± SEM for time spent awake (a), in non-rapid eye movement sleep (NREM; b), and rapid eye movement sleep (REM; c) over a 24-h period in Townes mice with the sickle cell phenotype SS (n = 6) and Townes mice with the sickle cell trait AS (n = 6). Statistical differences determined by two-tailed unpaired Student’s t test
Fig. 2
Fig. 2
Mean ± SEM for number (a) and duration (c) of non-rapid eye movement (NREM) sleep bouts and number (b) and duration (d) of rapid eye movement (REM) sleep bouts over a 24-h period in Townes mice with the sickle cell phenotype SS (n = 6) and Townes mice with the sickle cell trait AS (n = 6). Statistical differences determined by two-tailed unpaired Student’s t test
Fig. 3
Fig. 3
Mean ± SEM for number of arousals per hour of sleep (a) and time to resume sleep (b) over a 24-h period in Townes mice with the sickle cell phenotype SS (n = 6) and Townes mice with the sickle cell trait AS (n = 6). Statistical differences determined by two-tailed unpaired Student’s t test
See this image and copyright information in PMC

References

    1. Bonds DR. Three decades of innovation in the management of sickle cell disease: the road to understanding the sickle cell disease clinical phenotype. Blood Rev. 2005;19(2):99–110. doi: 10.1016/j.blre.2004.04.002. - DOI - PubMed
    1. Embury S, Hebbel RP, Mohandas N, Steinberg MH. Sickle cell disease: basic principles and clinical practice. New York: Raven Press; 1995.
    1. Buchanan GR, DeBaun MR, Quinn CT, et al. Sickle cell disease. Hematology: Am Soc Hematol Educ Program. 2004;1:35–47. doi: 10.1182/asheducation-2004.1.35. - DOI - PubMed
    1. Rosen CL, Debaun MR, Strunk RC, Redline S, Seicean S, Craven DI, Gavlak JCD, Wilkey O, Inusa B, Roberts I, Goodpaster RL, Malow B, Rodeghier M, Kirkham FJ. Obstructive sleep apnea and sickle cell anemia. Pediatrics. 2014;134(2):273–281. doi: 10.1542/peds.2013-4223. - DOI - PMC - PubMed
    1. Rogers VE, Lewin DS, Winnie GB, Greiger-Brown J. Polysomnographic characteristics of a referred sample of children with SCD. J Clinical Sleep Med. 2010;6(4):374–381. - PMC - PubMed